X
AbbVie leads $53m investment macrophage cancer tech
https://pharmaphorum.com/news/53m-investment-carisma-therapeutics/
News
Aimmune to file peanut allergy treatment by year-end
Backed by a $202 million fundraiser, biotech Aimmune has announced plans to file its potential peanut allergy treatment at the end of the year following a phase 3 trial success.
Breath Biopsy company adds new investor to $15m fundraising
Owlstone Medical, the innovative company which promises to revolutionise the diagnosis of cancer by simply analysing a patient’s breath has been given a major funding boost.
Microsoft and Google among funders for cloud-based R&D startup
DNAnexus focuses on cloud-based R&D
